KAYE EDWARD M. MD

PrivateCIK: 1522780

Location

BEDFORD, MA

Senior insider sale

CEO at STOKE THERAPEUTICS, INC. — senior position signals high conviction

$38.82M

1.51M shares

What this filing means

KAYE EDWARD M. MD plans to sell 1.51M shares of STOKE THERAPEUTICS, INC. valued at approximately $38.82M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.

KAYE EDWARD M. MD

Filed: 10/21/2026ACC: 0001950047-26-010349

InsiderKAYE EDWARD M. MDCIK 1522780

→

IssuerSTOKE THERAPEUTICS, INC.CIK 1623526

DirectorOfficer· CEO

Since Jun 2019

1.51M

Shares to sell

$38.82M

Approx. market value

1.50M

Acquired (3 months)

1

Planned

1 completed

Securities Acquired — Last 3 Months15

Sort

Exercise of Options Under a Registered Plan

Cash

10/21/2026

15.36K

Exercise of Options Under a Registered Plan

Cash

10/21/2026

27.44K

Exercise of Options Under a Registered Plan

Cash

10/21/2026

88.82K

Exercise of Options Under a Registered Plan

Cash

10/21/2026

3.00

Exercise of Options Under a Registered Plan

Cash

10/21/2026

416.88K

Exercise of Options Under a Registered Plan

Cash

10/21/2026

187.12K

Exercise of Options Under a Registered Plan

Cash

10/21/2026

4.92K

Exercise of Options Under a Registered Plan

Cash

10/21/2026

92.32K

Exercise of Options Under a Registered Plan

Cash

10/21/2026

67.79K

Exercise of Options Under a Registered Plan

Cash

10/21/2026

303.08K

Exercise of Options Under a Registered Plan

Cash

10/21/2026

186.38K

Exercise of Options Under a Registered Plan

Cash

10/21/2026

9.88K

Exercise of Options Under a Registered Plan

Cash

10/21/2026

37.50K

Exercise of Options Under a Registered Plan

Cash

10/21/2026

7.05K

Exercise of Options Under a Registered Plan

Cash

10/21/2026

51.50K

Total acquired1.50M

Acquisition Date	Type	Amount Acquired	Gift
10/21/2026	Exercise of Options Under a Registered Plan Cash	15.36K	—
10/21/2026	Exercise of Options Under a Registered Plan Cash	27.44K	—
10/21/2026	Exercise of Options Under a Registered Plan Cash	88.82K	—
10/21/2026	Exercise of Options Under a Registered Plan Cash	3.00	—
10/21/2026	Exercise of Options Under a Registered Plan Cash	416.88K	—
10/21/2026	Exercise of Options Under a Registered Plan Cash	187.12K	—
10/21/2026	Exercise of Options Under a Registered Plan Cash	4.92K	—
10/21/2026	Exercise of Options Under a Registered Plan Cash	92.32K	—
10/21/2026	Exercise of Options Under a Registered Plan Cash	67.79K	—
10/21/2026	Exercise of Options Under a Registered Plan Cash	303.08K	—
10/21/2026	Exercise of Options Under a Registered Plan Cash	186.38K	—
10/21/2026	Exercise of Options Under a Registered Plan Cash	9.88K	—
10/21/2026	Exercise of Options Under a Registered Plan Cash	37.50K	—
10/21/2026	Exercise of Options Under a Registered Plan Cash	7.05K	—
10/21/2026	Exercise of Options Under a Registered Plan Cash	51.50K	—
Total		1.50M

Planned & Completed Dispositions2

Sort

Completed

—Completed

Units to sell

12.57K

Market value

$402.5K

8/14/2026

Planned — Approximate Date

NASDAQPlanned

Units to sell

1.50M

Market value

$38.42M

10/21/2026

Total

Units

1.51M

Value

$38.82M

Date	Units to Sell	Approx. Market Value	Exchange	Status
Completed
8/14/2026	12.57K	$402.5K	—	Completed
Planned — Approximate Date
10/21/2026	1.50M	$38.42M	NASDAQ	Planned
Total	1.51M	$38.82M

KAYE EDWARD M. MD — Planned Insider Sale (Form 144) | Finecho